The Nordic headquarters of Danish medical dermatology specialist LEO Pharma sits in Sweden, led by the recently appointed Klaus Abel. Abel discusses the importance of Sweden to the global group, its ambitious goal of helping 125 million patients by 2025, and the leading role that the Nordics has to play in this endeavour.
From a financial point of view, the Nordic region is a relatively small proportion of the group's revenue, but it is an important one because it is the home market, with a lot of tradition and long-standing relationships
